Literature DB >> 25585033

Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study.

Matthew E Peters1, Sarah Schwartz, Dingfen Han, Peter V Rabins, Martin Steinberg, Joann T Tschanz, Constantine G Lyketsos.   

Abstract

OBJECTIVE: Little is known about factors influencing the rate of progression of Alzheimer's dementia. Using data from the Cache County Dementia Progression Study, the authors examined the link between clinically significant neuropsychiatric symptoms in mild Alzheimer's dementia and progression to severe dementia or death.
METHOD: The Cache County Dementia Progression Study is a longitudinal study of dementia progression in incident cases of this condition. Survival analyses included unadjusted Kaplan-Meier plots and multivariate Cox proportional hazard models. Hazard ratio estimates controlled for age at dementia onset, dementia duration at baseline, gender, education level, General Medical Health Rating, and apolipoprotein E epsilon 4 genotype.
RESULTS: Three hundred thirty-five patients with incident Alzheimer's dementia were studied. Sixty-eight (20%) developed severe dementia over the follow-up period. Psychosis (hazard ratio=2.007), agitation/aggression (hazard ratio=2.946), and any one clinically significant neuropsychiatric symptom (domain score ≥4, hazard ratio=2.682) were associated with more rapid progression to severe dementia. Psychosis (hazard ratio=1.537), affective symptoms (hazard ratio=1.510), agitation/aggression (hazard ratio=1.942), mildly symptomatic neuropsychiatric symptoms (domain score of 1-3, hazard ratio=1.448), and clinically significant neuropsychiatric symptoms (hazard ratio=1.951) were associated with earlier death.
CONCLUSIONS: Specific neuropsychiatric symptoms are associated with shorter survival time from mild Alzheimer's dementia to severe dementia and/or death. The treatment of specific neuropsychiatric symptoms in mild Alzheimer's dementia should be examined for its potential to delay time to severe dementia or death.

Entities:  

Mesh:

Year:  2015        PMID: 25585033      PMCID: PMC4416978          DOI: 10.1176/appi.ajp.2014.14040480

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  18 in total

1.  APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

Authors:  J C Breitner; B W Wyse; J C Anthony; K A Welsh-Bohmer; D C Steffens; M C Norton; J T Tschanz; B L Plassman; M R Meyer; I Skoog; A Khachaturian
Journal:  Neurology       Date:  1999-07-22       Impact factor: 9.910

2.  Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.

Authors:  Constantine G Lyketsos; Christopher C Colenda; Cornelia Beck; Karen Blank; Murali P Doraiswamy; Douglas A Kalunian; Kristine Yaffe
Journal:  Am J Geriatr Psychiatry       Date:  2006-07       Impact factor: 4.105

Review 3.  Predicting cognitive decline in Alzheimer's disease: an integrated analysis.

Authors:  Oscar L Lopez; Elias Schwam; Jeffrey Cummings; Serge Gauthier; Roy Jones; David Wilkinson; Gunhild Waldemar; Richard Zhang; Rachel Schindler
Journal:  Alzheimers Dement       Date:  2010-11       Impact factor: 21.566

4.  Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.

Authors:  JoAnn T Tschanz; Chris D Corcoran; Sarah Schwartz; Katherine Treiber; Robert C Green; Maria C Norton; Michelle M Mielke; Kathleen Piercy; Martin Steinberg; Peter V Rabins; Jeanne-Marie Leoutsakos; Kathleen A Welsh-Bohmer; John C S Breitner; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2011-06       Impact factor: 4.105

5.  Predicting time to nursing home care and death in individuals with Alzheimer disease.

Authors:  Y Stern; M X Tang; M S Albert; J Brandt; D M Jacobs; K Bell; K Marder; M Sano; D Devanand; S M Albert; F Bylsma; W Y Tsai
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

6.  The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia.

Authors:  C G Lyketsos; E Galik; C Steele; M Steinberg; A Rosenblatt; A Warren; J M Sheppard; A Baker; J Brandt
Journal:  J Am Geriatr Soc       Date:  1999-04       Impact factor: 5.562

Review 7.  The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.

Authors:  J L Cummings
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

8.  Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis.

Authors:  Joost Witlox; Lisa S M Eurelings; Jos F M de Jonghe; Kees J Kalisvaart; Piet Eikelenboom; Willem A van Gool
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

9.  Apathy syndrome in Alzheimer's disease epidemiology: prevalence, incidence, persistence, and risk and mortality factors.

Authors:  Joan Vilalta-Franch; Laia Calvó-Perxas; Josep Garre-Olmo; Oriol Turró-Garriga; Secundino López-Pousa
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Atypical antipsychotic use in patients with dementia: managing safety concerns.

Authors:  Martin Steinberg; Constantine G Lyketsos
Journal:  Am J Psychiatry       Date:  2012-09       Impact factor: 18.112

View more
  83 in total

Review 1.  Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning.

Authors:  Aaron M Koenig; Steven E Arnold; Joel E Streim
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

2.  Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.

Authors:  Elise A Weamer; Mary Ann A DeMichele-Sweet; Yona K Cloonan; Oscar L Lopez; Robert A Sweet
Journal:  J Clin Psychiatry       Date:  2016-12       Impact factor: 4.384

3.  Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease.

Authors:  Winnie Qian; Tom A Schweizer; Nathan W Churchill; Colleen Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; David G Munoz; Joseph J Barfett; Tarek K Rajji; Corinne E Fischer
Journal:  Am J Geriatr Psychiatry       Date:  2018-10-02       Impact factor: 4.105

4.  Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

Authors:  Zahinoor Ismail; Eric E Smith; Yonas Geda; David Sultzer; Henry Brodaty; Gwenn Smith; Luis Agüera-Ortiz; Rob Sweet; David Miller; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2015-06-18       Impact factor: 21.566

Review 5.  Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?

Authors:  Paul B Rosenberg; Milap A Nowrangi; Constantine G Lyketsos
Journal:  Mol Aspects Med       Date:  2015-06-03

6.  Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease.

Authors:  Tommaso Ballarini; Leonardo Iaccarino; Giuseppe Magnani; Nagehan Ayakta; Bruce L Miller; William J Jagust; Maria Luisa Gorno-Tempini; Gil D Rabinovici; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2016-07-13       Impact factor: 5.038

Review 7.  Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Authors:  Damien Gallagher; Corinne E Fischer; Andrea Iaboni
Journal:  Can J Psychiatry       Date:  2017-03       Impact factor: 4.356

8.  Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.

Authors:  Lirong Wang; Jian Ying; Peihao Fan; Elise A Weamer; Mary Ann A DeMichele-Sweet; Oscar L Lopez; Julia K Kofler; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-27       Impact factor: 4.105

9.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 10.  Towards defining restlessness in individuals with dementia.

Authors:  Natalie G Regier; Laura N Gitlin
Journal:  Aging Ment Health       Date:  2016-01-08       Impact factor: 3.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.